Compounded Semaglutide Fridge Storage: Stability & Safety

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Unopened compounded semaglutide stored at 2–8°C (36–46°F) typically remains stable for approximately 30 days, though the exact duration depends on the specific compounding pharmacy's formulation, vial type, and storage conditions. Most licensed 503A compounding pharmacies provide stability data and expiration guidance specific to their preparation.

Proper storage directly impacts medication potency and safety. Understanding how long your compounded semaglutide remains viable helps you plan treatment initiation, manage refill timing, and avoid wastage—all critical factors when beginning a GLP-1 protocol under provider supervision.

Compounded Semaglutide Stability: What the Science Shows

Compounded semaglutide stability depends on the active pharmaceutical ingredient (API), sterile diluent, preservatives, and vial closure system used by the 503A pharmacy. Unlike branded semaglutide (Ozempic, Wegovy), which undergoes rigorous FDA stability testing, each compounded preparation has its own stability profile determined by the compounding pharmacist.

Research on semaglutide degradation indicates that temperature fluctuations, light exposure, and repeated needle punctures accelerate potency loss. Most 503A compounding pharmacies assign a beyond-use date (BUD) of 30 days refrigerated, but this can vary. Always check the specific stability documentation provided with your medication.

Refrigeration Requirements and Storage Conditions Compared

Proper refrigeration is non-negotiable for compounded semaglutide. Temperature consistency, protection from light, and avoiding freezing all contribute to maintaining the medication's integrity throughout its shelf life. The following table outlines key storage factors and their impact on stability.

Storage Factor	Requirement	Impact if Violated
Temperature Range	2–8°C (36–46°F)	Freezing or warmth degrades semaglutide; potency loss accelerates above 8°C
Light Exposure	Store in dark or opaque container	UV and visible light catalyze chemical degradation of the active ingredient
Needle Punctures	Minimize to once per use only	Each puncture introduces air and may compromise sterility; limit to necessary withdrawals
Humidity Control	Keep away from moisture; do not open until use	Moisture ingress can promote bacterial growth and chemical degradation over time

Timeline for Starting Treatment After Receiving Your Medication

Once you receive your compounded semaglutide, confirm the beyond-use date (BUD) or expiration printed on the vial or provided in documentation. If you plan to start treatment immediately, stability is not a concern; if there will be a delay, ensure the medication is properly refrigerated and used within the assigned timeframe.

Many patients receive their compounded semaglutide and hold it for 1–2 weeks before beginning dosing. Check your stability window with your pharmacy; most 30-day BUDs provide sufficient time for this. Plan your first injection before the expiration date to avoid medication loss.

Safety Considerations and When to Discard Compounded Semaglutide

If your compounded semaglutide has exceeded its beyond-use date, shows visible cloudiness, discoloration, or particulates, or has been left unrefrigerated for more than 2 hours, discard it safely according to local medication disposal guidelines. Do not use expired or compromised medication, as potency cannot be guaranteed.

Before starting any compounded GLP-1 therapy, work with your healthcare provider to confirm your baseline metabolic markers—including fasting glucose, HbA1c, lipid profile, and kidney function—to establish safe dosing and monitor response. Proper storage ensures the medication you use is potent and safe.

How PlexusDx Supports a More Personalized Approach

Understanding your medication's stability window is part of precision treatment planning at PlexusDx. Biomarkers such as baseline fasting glucose, HbA1c, and metabolic rate may help your provider determine when starting compounded semaglutide is most appropriate for your goals, ensuring the medication maintains full potency when you begin.

The PlexusDx Precision Peptide Genetic Test may help provide context about your predisposition in GLP-1 receptor and metabolic pathways—variants such as FTO rs9939609. While genetic data does not predict exact medication response, it can support a more informed conversation with your provider about whether compounded semaglutide aligns with your physiology and treatment readiness.

Combining proper storage practices with baseline biomarker assessment and genetic insights creates a more personalized approach to GLP-1 therapy. When your provider knows both your medication's stability status and your individual metabolic and genetic profile, dosing decisions and timing can be more precise.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Why does a compounded preparation carry a different expiration than the branded product?

Because each preparation is unique. The article says branded semaglutide undergoes rigorous FDA stability testing, while a compounded version's stability profile depends on the active ingredient, sterile diluent, preservatives and vial closure system chosen by the 503A pharmacy. That is why the pharmacy that prepared it assigns and documents its own dating.

What is a beyond-use date, and where would a patient find theirs?

A beyond-use date, or BUD, is the point past which a compounded preparation should no longer be used. The article says most 503A pharmacies assign one and supply stability documentation with the medication, printed on the vial or included in the paperwork. It directs patients to that documentation rather than to any standard window.

Which conditions does the article say degrade the medication fastest?

Temperature fluctuation, light exposure and repeated needle punctures. The article says research on semaglutide degradation points to all three as accelerating potency loss, and its table adds that both freezing and excess warmth are damaging. The handling requirements that actually apply come from the dispensing pharmacy's instructions for that specific preparation.

What would make a vial no longer usable?

The article names an exceeded beyond-use date, visible cloudiness, discoloration or particulates in the vial, and a prolonged stretch outside refrigeration. It says compromised medication should not be used because potency can no longer be guaranteed, and that disposal follows local medication disposal guidelines. Anything questionable is a call for the dispensing pharmacy.

What should be established with a provider before the first dose?

The article says baseline metabolic markers should be confirmed with the healthcare provider, naming fasting glucose, HbA1c, a lipid profile and kidney function. It presents that as the groundwork both for safe treatment and for monitoring response later, and pairs it with using medication that has been stored and dispensed per the pharmacy's own guidance.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Do Genetics Affect How Long My Reproductive Years Will Last
• Medvi Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.